Jeffrey L. Cummings MD, ScD

Jeffrey Cummings, MD, ScD, is the Joy Chambers-Grundy Professor of Brain Science and Director of the Chambers-Grundy Center for Transformative Neuroscience at the Kirk Kerkorian School of Medicine at the University of Nevada, Las Vegas (UNLV). An internationally recognized neurologist, he is a leading expert in Alzheimer’s disease research, neurodegenerative disorders, drug development, and clinical trials.

Dr. Cummings leads the Biomarker Observatory and the UNLV Clinical Trials Observatory, which evaluate emerging therapies and ongoing clinical trials for Alzheimer’s disease to inform drug development strategies. He also serves as Co-Director of the Pam Quirk Brain Health and Biomarker Laboratory and the Alzheimer’s Disease and Related Dementias Innovation Incubator.

An accomplished author and researcher, Dr. Cummings has published 43 books and more than 900 peer-reviewed scientific papers focusing on Alzheimer’s disease, neuropsychiatry, and clinical trials. His contributions to neuroscience and therapeutic development have earned him numerous prestigious honors, including the Bengt Winblad Lifetime Achievement Award from the Alzheimer’s Association and the Melvin R. Goodes Prize for Excellence in Drug Development from the Alzheimer’s Drug Discovery Foundation.

Before joining UNLV, Dr. Cummings held several prominent leadership positions, including founding director of the Mary S. Easton Center for Alzheimer’s Disease Research and the Deane F. Johnson Center for Neurotherapeutics at the University of California, Los Angeles (UCLA), as well as founding director of the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas.

He completed his neurology and behavioral neurology training at Boston University, followed by additional training in neuropsychiatry and neuropathology at the National Hospital for Nervous Diseases in Queen Square, London.